Targeted Qualitative Insights from Endocrinologists and Payers to Inform High-Stakes Healthcare Decisions
Konovo’s Rare Disease & Endocrinology Qualitative Full-Service Case Study showcases how our agile, end-to-end US research solution empowered a healthcare services provider to assess the market potential of a rare disease treatment asset. Using the Konovo I2 platform, we conducted 30-minute web-enabled interviews with six endocrinologists treating rare disease patients and five US-based payers managing specialty pharmaceuticals. Our approach included expert study design, rapid recruitment of specialized respondents, live moderation, and comprehensive reporting—all completed within seven business days. The resulting market intelligence provided clear, actionable insights, enabling the client to make an informed acquisition decision with confidence
